Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,376,738 papers from all fields of science
Search
Sign In
Create Free Account
Eplivanserin Hemifumarate
Known as:
(4-((1E,3Z)-3-((2-(Dimethylamino)Ethoxy)Imino)-3-(2-Fluorophenyl)Prop-1- Enyl)Phenol)(2E)-2-Butenedioate (2:1)
, 2-Propen-1-One, 1-(2-Fluorophenyl)-3-(4-Hydroxyphenyl)-, O-(2- (Dimethylamino)Ethyl)Oxime, (1z,2e)-, (2e)-2-Butenedioate (2:1)
, SR46349B
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Eplivanserin
Narrower (1)
SR 46349B
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour.
M. Orejarena
,
L. Lanfumey
,
R. Maldonado
,
P. Robledo
International Journal of Neuropsychopharmacology
2011
Corpus ID: 1749952
The serotonergic system appears crucial for (±)-3,4-methylenedioxymethamphetamine (MDMA) reinforcing properties. Current evidence…
Expand
2011
2011
The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B
Laura Scarlota
,
J. Harvey
,
V. Aloyo
Psychopharmacology
2011
Corpus ID: 5904682
RationaleAtypical antipsychotic efficacy is often attributed to actions at serotonin-2 (5-HT2) and dopamine receptors, indicating…
Expand
2009
2009
Inhibition of Monoamine Oxidases Desensitizes 5-HT1A Autoreceptors and Allows Nicotine to Induce a Neurochemical and Behavioral Sensitization
C. Lanteri
,
Sandra Jimena Hernández Vallejo
,
+5 authors
J. Tassin
Journal of Neuroscience
2009
Corpus ID: 5228352
Although nicotine is generally considered to be the main compound responsible for addictive properties of tobacco, experimental…
Expand
2007
2007
Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors
L. Salomon
,
C. Lanteri
,
G. Godeheu
,
G. Blanc
,
J. Gingrich
,
J. Tassin
Psychopharmacology
2007
Corpus ID: 23543786
RationaleAlthough locomotor response to d-amphetamine is considered as mediated by an increased release of dopamine in the…
Expand
2007
2007
Opportunities for isotopic labelling via phase‐tagged synthesis with organogermanium linkers
A. Spivey
,
Laetitia J. Martin
,
C. Noban
,
T. Jones
,
G. Ellames
,
A. Kohler
2007
Corpus ID: 27804453
Strategies for the use of germanium-based linkers for the phase-tagged synthesis of isotopically labelled intermediates are…
Expand
Highly Cited
2006
Highly Cited
2006
Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons.
L. Salomon
,
C. Lanteri
,
J. Glowinski
,
J. Tassin
Proceedings of the National Academy of Sciences…
2006
Corpus ID: 5672516
In rodents, drugs of abuse induce locomotor hyperactivity, and repeating injections enhances this response. This effect, called…
Expand
2005
2005
Clozapine increases cutaneous blood flow and reduces sympathetic cutaneous vasomotor alerting responses (SCVARs) in rats: comparison with effects of haloperidol
W. Blessing
Psychopharmacology
2005
Corpus ID: 31829938
RationaleClozapine inhibits sympathetic outflow to the cutaneous vascular bed. Clozapine reverses hyperthermia and cutaneous…
Expand
2004
2004
Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
A. Auclair
,
G. Blanc
,
J. Glowinski
,
J. Tassin
Journal of Neurochemistry
2004
Corpus ID: 40269722
D-amphetamine is known to induce an increase in dopamine release in subcortical structures, thus inducing locomotor hyperactivity…
Expand
2002
2002
Regulation of striatal neuropeptide mRNAs: Effects of the 5‐HT2 antagonist SR46349B in adult rats with a neonatal 6‐hydroxydopamine lesion
C. Durand
,
A. Mathieu-Kia
,
M. Besson
,
J. Penit-Soria
Journal of Neuroscience Research
2002
Corpus ID: 8807394
The intrastriatal injection of 6‐hydroxydopamine (6‐OHDA) in newborn rats produces a marked striatal dopamine (DA) depletion…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE